Article Versions Notes

Rivas-Urbina A, Rull A, Aldana-Ramos J, Santos D, Puig N, Farre-Cabrerizo N, Benitez S, Perez A, de Gonzalo-Calvo D, Escola-Gil JC, et al. Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice. Biomolecules. 2020; 10(6):829. https://doi.org/10.3390/biom10060829

Rivas-Urbina, Andrea, Anna Rull, Joile Aldana-Ramos, David Santos, Nuria Puig, Nuria Farre-Cabrerizo, Sonia Benitez, Antonio Perez, David de Gonzalo-Calvo, Joan Carles Escola-Gil, and et al. 2020. "Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice" Biomolecules 10, no. 6: 829. https://doi.org/10.3390/biom10060829

Rivas-Urbina, A., Rull, A., Aldana-Ramos, J., Santos, D., Puig, N., Farre-Cabrerizo, N., Benitez, S., Perez, A., de Gonzalo-Calvo, D., Escola-Gil, J. C., Julve, J., Ordoñez-Llanos, J., & Sanchez-Quesada, J. L. (2020). Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice. Biomolecules, 10(6), 829. https://doi.org/10.3390/biom10060829